Tevano Systems Holdings Inc. (TEVNF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | - CAD | -100.0% |
| 2022 | 4.72 Million CAD | -17.33% |
| 2021 | 5.71 Million CAD | 17669.99% |
| 2020 | 32.14 Thousand CAD | -49.92% |
| 2019 | 64.18 Thousand CAD | -76.58% |
| 2018 | 274.05 Thousand CAD | -56.85% |
| 2017 | 635.06 Thousand CAD | -45.23% |
| 2016 | 1.15 Million CAD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | - CAD | 0.0% |
| 2023 Q2 | 184.51 Thousand CAD | -43.17% |
| 2023 Q1 | 324.66 Thousand CAD | -26.55% |
| 2023 FY | - CAD | -100.0% |
| 2023 Q3 | 458.67 Thousand CAD | 148.58% |
| 2023 Q4 | - CAD | -100.0% |
| 2022 Q3 | 691.78 Thousand CAD | -74.93% |
| 2022 Q1 | 903.88 Thousand CAD | -71.05% |
| 2022 FY | 4.72 Million CAD | -17.33% |
| 2022 Q4 | 442.01 Thousand CAD | -36.1% |
| 2022 Q2 | 2.75 Million CAD | 205.28% |
| 2021 Q1 | 326.59 Thousand CAD | 0.0% |
| 2021 FY | 5.71 Million CAD | 17669.99% |
| 2021 Q3 | 1.51 Million CAD | 0.0% |
| 2021 Q4 | 3.12 Million CAD | 105.83% |
| 2020 FY | 32.14 Thousand CAD | -49.92% |
| 2020 Q3 | 295.56 Thousand CAD | 0.0% |
| 2019 FY | 64.18 Thousand CAD | -76.58% |
| 2018 FY | 274.05 Thousand CAD | -56.85% |
| 2017 FY | 635.06 Thousand CAD | -45.23% |
| 2016 FY | 1.15 Million CAD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| American Medical Technologies Inc. | 2.86 Million USD | 100.0% |
| Ansell Limited | 495.5 Million USD | 100.0% |
| Ansell Limited | 495.5 Million USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | 82.8 Million USD | 100.0% |
| BioLife Sciences Inc. | - USD | NaN% |
| CB Scientific, Inc. | 1.73 Million USD | 100.0% |
| Psykey, Inc. | 1.21 Million USD | 100.0% |
| ConvaTec Group Plc | 910.31 Million USD | 100.0% |
| ConvaTec Group Plc | 872.5 Million USD | 100.0% |
| Encision Inc. | 3.77 Million USD | 100.0% |
| Golden Valley Development, Inc | 141.81 Thousand USD | 100.0% |
| Hear AtLast Holdings, Inc. | 109.93 Thousand USD | 100.0% |
| Innovative MedTech Inc. | 6.09 Million USD | 100.0% |
| LifePoint, Inc. | 7.42 Million USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | 6.34 Million USD | 100.0% |
| Paradigm Medical Industries, Inc. | 855 Thousand USD | 100.0% |
| QuantRx Biomedical Corporation | - USD | NaN% |
| Remedent, Inc. | 726.13 Thousand USD | 100.0% |
| Reflect Scientific, Inc. | 1.06 Million USD | 100.0% |
| SmileDirectClub, Inc. | 517 Million USD | 100.0% |
| Sector 10, Inc. | 39.84 Thousand USD | 100.0% |
| Shandong Weigao Group Medical Polymer Company Limited | 6.64 Billion USD | 100.0% |
| SheerVision, Inc. | 2.33 Million USD | 100.0% |
| United Health Products, Inc. | 2.42 Million USD | 100.0% |
| Vasamed, Inc. | 4.67 Million USD | 100.0% |
| Wearable Health Solutions, Inc. | 2.56 Million USD | 100.0% |
| Yubo International Biotech Limited | 1.25 Million USD | 100.0% |